Literature DB >> 406416

Prevention of Rh-hemolytic disease.

O A Ladipo, A S David-West.   

Abstract

The results of Anti (D) immunoglobulin (RhoGAM) therapy in 25 Rh-negative women after delivery of Rh-positive babies are presented. None of the patients studied showed evidence of Rh-isoimmunization while two of 51 unprotected patients subsequently had antibodies detected in their serum. The incidence of Rh-negative patients is low in this environment. Because of the potential risk of isoimmunization, RhoGAM prophylaxis is advocated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406416      PMCID: PMC2536928     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  11 in total

1.  SELECTION AGAINST THE RH-NEGATIVE GENE BY MALARIA.

Authors:  J G GORMAN
Journal:  Nature       Date:  1964-05-16       Impact factor: 49.962

2.  THE DEMONSTRATION OF FETAL ERYTHROCYTES IN THE PRESENCE OF ADULT RED BLOOD CELLS.

Authors:  E M CLAYTON; W D FELDHAUS; J M PHYTHYON
Journal:  Am J Clin Pathol       Date:  1963-11       Impact factor: 2.493

3.  Foetal erythrocytes in the maternal circulation.

Authors:  A ZIPURSKY; A HULL; F D WHITE; L G ISRAELS
Journal:  Lancet       Date:  1959-02-28       Impact factor: 79.321

4.  The influence of the ABO system on Rh hemolytic disease.

Authors:  P LEVINE
Journal:  Hum Biol       Date:  1958-02       Impact factor: 0.553

5.  The frequency of immunization of Rh-negative women by Rh antigens.

Authors:  K CLEMENS; R J WALSH
Journal:  Med J Aust       Date:  1954-10-30       Impact factor: 7.738

6.  Results of clinical trials of RhoGAM in women.

Authors:  W Pollack; J G Gorman; V J Freda; W Q Ascari; A E Allen; W J Baker
Journal:  Transfusion       Date:  1968 May-Jun       Impact factor: 3.157

7.  Rhesus immunization in Nigeria.

Authors:  S Worlledge; L Luzzatto; S E Ogiemudia; P Luzzatto; G M Edington
Journal:  Vox Sang       Date:  1968       Impact factor: 2.144

8.  Transplacental haemorrhage.

Authors:  J C Woodrow; R Finn
Journal:  Br J Haematol       Date:  1966-05       Impact factor: 6.998

9.  Rho (D) immune prophylaxis. A double-blind cooperative study.

Authors:  C A White; R D Visscher; H C Visscher; M E Wade
Journal:  Obstet Gynecol       Date:  1970-09       Impact factor: 7.661

10.  Transplacental fetal-maternal hemorrhage.

Authors:  J F Sullivan; E R Jennings
Journal:  Am J Clin Pathol       Date:  1966-07       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.